Company intelligence / Profile preview

NeuroEnabling Technologies

Los Angeles, California, United Statespatents.google.com ↗

Ownership: Private
Development stage: Commercial

Overview

Conducted early-stage clinical research on non-invasive spinal neuromodulation to restore upper limb function in individuals with paralysis due to spinal cord injury. Principal investigator listed as Nicholas Terrafranca. No published late-stage or commercial results found.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Not publicly disclosed

Beyond the preview

Go deeper on NeuroEnabling Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroEnabling Technologies.

Explore the full profile